TrialAmerican journal of hematology2016

Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naïve patients with Gaucher disease.

Ari Zimran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.